background preloader


Facebook Twitter

One pill makes us larger ; one pill makes us small …
… and the ones that Another gives don’t do anything at All
~ paraphrase Jefferson Airplane in deliberation consideration ~

Conference Report: Traditions of Materia Medica: 300BCE–1300CE – The Recipes Project. By Sean Coughlin On 16–18 June 2021, members of the research group A03 at the DFG-funded SFB 980 ‘Episteme in Motion’ and the Institute of Classical Philology, Humboldt-Universität in Berlin (Sean Coughlin, Christine Salazar, Lisa Sherbakova, Kristiane Hasselmann, Philip van der Eijk) held a conference called Traditions of Materia Medica: 300 BCE–1300CE. Over the three days, 25 speakers and over 50 guests from around the world met remotely to share research on the history of theoretical pharmacology in the immediate vicinity of Galen of Pergamum.

One goal for the conference was practical: to bring each other up to speed on what we’ve been doing since the start of the pandemic. Another was programmatic: to test the hypothesis that Galen’s writings on pharmacology constitute a key moment in the history of theoretical pharmacology, one that brought about an acceleration of pharmacological research and reflection. Galen’s Immediate Predecessors (3rd c. Galen’s Descendants (3rd – 13th c. The Working of Herbs – The Recipes Project. Italian Book of Secrets Database. Dataset posted on 24.03.2009, 15:21by Tessa Storey As a genre, 'Books of Secrets' (Libri di Secreti or, more generically, ricettari) first flourished during the middle ages. They were technical, crafts-based 'how-to-do it' manuals, 'secret' because they were written in Latin and available only to the privileged few.

With the advent of the printing press, vernacular editions started to appear—the first in Italian was the Opera Nuova intitolata Dificio di ricette in 15271 —and by the mid-sixteenth century secrets books were flooding off the presses. They tended to contain instructions for the making of medicines, recipes for preserving food, recipes pertaining to domestic management (such as making inks and removing stains), some for cosmetics and some 'alchemical' recipes, for refining chemicals. History Publisher School of Historical Studies, University of Leicester. Available date Associated authors Gentilcore, David; Pearson, Sandy Language en.

Chinese American Herbal Medicine: A History of Importation and Improvisation – The Recipes Project. By Tamara Venit Shelton “Chinese herbalists imported everything from China.” This is what I consistently heard from herbalists I interviewed when writing Herbs and Roots: A History of Chinese Doctors in the American Medical Marketplace. As far as anyone knew, when the first generation of Chinese herbalists began to immigrate to the United States in the 1850s, they imported all their medicinal ingredients from China through the port of San Francisco. By 1878, there were eighteen wholesale companies in San Francisco that serviced Chinese herb shops across the United States. In later years, herbalists could find what they needed through wholesalers in Portland, Seattle, St. Louis, and Chicago. [i] Historians of China are aware of the importance of improvisation and substitution in traditional Chinese medicine, and yet the prevalent assumption that all Chinese medicines were imported to the United States made some sense.

Zoological-based medicines also seem to have been locally sourced. Home | Pharmacological Reviews. Bristol Myers Squibb - U.S. Food and Drug Administration Approves Opdivo® (nivolumab) for the Adjuvant Treatment of Patients with High-Risk Urothelial Carcinoma. In CheckMate -274, Opdivo nearly doubled median disease-free survival compared to placebo in the intent-to-treat population1 Opdivo is now approved in earlier stages of disease for three types of cancer, including the first and only PD-1 inhibitor approved for urothelial carcinoma in the adjuvant setting PRINCETON, N.J.

--(BUSINESS WIRE)-- Bristol Myers Squibb (NYSE: BMY) today announced that Opdivo®(nivolumab) 240 mg every two weeks or 480 mg every four weeks (injection for intravenous use) was approved by the U.S. “This approval is a major milestone for patients who have undergone major surgery to remove the bladder or parts of the urinary tract and are in need of additional treatment approaches that can help reduce the risk of their UC returning,” said Matthew D. About CheckMate -274 Select Safety Profile from CheckMate -274 Study About Urothelial Carcinoma Severe and Fatal Immune-Mediated Adverse Reactions Immune-Mediated Pneumonitis OPDIVO can cause immune-mediated pneumonitis.

Lactation. Psychiatry Online. Neuroplasticity as a target for the pharmacotherapy of anxiety disorders, mood disorders, and schizophrenia.


Tiagabine - an overview | ScienceDirect Topics. Herbaria. Entheogens.